Search results
Swiss pharma firm Lonza's profit falls less than feared, shares rise
Reuters via Yahoo Singapore Finance· 4 days ago(Reuters) -Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in...
This Is How Llamas Could Be The Future Of HIV Immunity
HuffPost UK via Yahoo News Singapore· 6 days agoThese new antibodies can do this in an easier way.” Researchers explained that this research...
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel,...
Benzinga via Yahoo Singapore Finance· 3 days agoThe companies seek approval for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal ...
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage...
Benzinga via Yahoo Singapore Finance· 6 days agoClesrovimab is the company’s investigational prophylactic monoclonal antibody designed to protect...
CytomX Therapeutics, Inc. (CTMX): The Best One-Dollar Stock to Buy Now?
Insider Monkey via Yahoo Singapore Finance· 4 days agoWe recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are...
Analysis-Drug giants eye China for deals despite growing Sino-US tensions
Reuters via Yahoo Singapore Finance· 6 days agoSome of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for...
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And...
Benzinga via Yahoo Singapore Finance· 4 days agoOn Thursday, AbbVie Inc. (NYSE:ABBV) reported second-quarter adjusted EPS of $2.65, down 8.9% year...
Early West Nile activity may point to a once-in-a-decade spike in infections. Here’s what survivors...
CNN via Yahoo News Singapore· 2 days agoBrittany Yeager was leading a troop of girls at Girl Scout camp in Idaho last summer when a mosquito...
Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges...
Benzinga via Yahoo Singapore Finance· 4 days agoThursday, Chemomab Therapeutics Ltd. (NASDAQ:CMMB) released topline results from the Phase 2 SPRING...
NICE's methodology means people with cancer aren't getting drugs - AstraZeneca's Sir Pascal Soriot...
Sky News via Yahoo News Singapore· 4 days agoThe chief executive of AstraZeneca has criticised a public health body for refusing to make one of...